Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
Open | $14.440 |
Close | - |
Volume / Avg. | 2.375K / 32.881K |
Day Range | 14.250 - 14.530 |
52 Wk Range | 3.800 - 19.600 |
Market Cap | $84.521M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 0.85% |
Days to Cover | 2.86 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Curis (NASDAQ: CRIS) through any online brokerage.
Other companies in Curis’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP), Elicio Therapeutics (NASDAQ:ELTX) and Gritstone Bio (NASDAQ:GRTS).
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on Friday, February 9, 2024. The analyst firm set a price target for 26.00 expecting CRIS to rise to within 12 months (a possible 81.31% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Curis (NASDAQ: CRIS) is $14.34 last updated Today at April 26, 2024 at 11:35 AM EDT.
There are no upcoming dividends for Curis.
Curis’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Curis.
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.